Carbocyclic Patents (Class 514/763)
  • Patent number: 10300027
    Abstract: The present invention relates to compositions and methods of treating warts and other human papilloma virus (HPV) skin infections. The present invention relates to compositions and methods of treating skin cancer.
    Type: Grant
    Filed: November 4, 2014
    Date of Patent: May 28, 2019
    Assignee: Phio Pharmaceuticals Corp.
    Inventors: William R. Levis, Leonard L. Kaplan, John G. Callahan
  • Patent number: 10300040
    Abstract: Provided is a pharmaceutical formulation and a method associated therewith for treating inflammation. The pharmaceutical formulation includes therapeutically effective amounts of sesquiterpenes such as ?-caryophyllene and two flavonoids. The two flavonoids include baicalin and catechin.
    Type: Grant
    Filed: May 2, 2018
    Date of Patent: May 28, 2019
    Assignee: Primus Pharmaceuticals, Inc.
    Inventor: Masayoshi Yamaguchi
  • Patent number: 10206862
    Abstract: A supplement composition formulated to support the health of a human's hair skin and nails containing biotin, Haematococcus pluvialis algae, and Reishi.
    Type: Grant
    Filed: September 11, 2017
    Date of Patent: February 19, 2019
    Assignee: The Procter & Gamble Company
    Inventors: Jennifer Marie Toomey, Paul Schulick
  • Patent number: 10039740
    Abstract: Provided is a pharmaceutical formulation and a method associated therewith for treating inflammation. The pharmaceutical formulation includes therapeutically effective amounts of sesquiterpenes such as ?-caryophyllene and two flavonoids. The two flavonoids include baicalin and catechin.
    Type: Grant
    Filed: October 14, 2016
    Date of Patent: August 7, 2018
    Assignee: Primus Pharmaceuticals, Inc.
    Inventor: Masayoshi Yamaguchi
  • Patent number: 9610255
    Abstract: A dietary supplement is disclosed comprising lycopene and resveratrol in a range of ratio of lycopene:resveratrol from 1:10 to 10:1. Preferably, the ratio is 1:2 to 1:4. Lycopene is preferably of ?95% purity and resveratrol is of ?98% purity. Both lycopene and resveratrol may preferably comprise of nano-sized particles in crystal powder to optimize oral intake in the form of capsule or tablet. In small dosage, it should preferably include a minimum of 5 mg of lycopene and 10 mg of resveratrol. Various range of ratios of lycopene:resveratrol are provided for specific therapeutic purposes including 1:4 for symptomatic relief of arthritis, 1:2 for inhibiting melanoma or carcinoma malignancy, and 1:3 for inhibiting hyperlipoidemia. Generally, our dietary supplement composition may be used as an agent for anti-ageing, anti-oxidative, inhibiting cardiovascular diseases, relieving menopause symptoms and remission of post-operative cancer patients.
    Type: Grant
    Filed: November 7, 2014
    Date of Patent: April 4, 2017
    Assignee: HSIEHS BIOTECH (SINGAPORE) PTE LTD
    Inventor: Kun Lung Hsieh
  • Patent number: 9049884
    Abstract: The present disclosure relates to preterm infant formulas comprising lutein, lycopene, and beta-carotene, and the use of the preterm infant formulas to modulate inflammation, such as skin inflammation, in preterm infants. Also disclosed are methods of modulating the level of C-reactive protein in a preterm infant using preterm infant formulas comprising mixtures of carotenoids.
    Type: Grant
    Filed: November 19, 2010
    Date of Patent: June 9, 2015
    Assignee: ABBOTT LABORATORIES
    Inventor: Bridget Barrett-Reis
  • Patent number: 9012515
    Abstract: This invention is based on unexpected effect of at least one thickener to maintain suspension or dispersion of solid particles in an oil medium. Such effect of thickener enables significant higher weight ratio of solid particles in such suspension composition as compared to previously known compositions. As a consequence, the suspension compositions provided herein enable more active ingredient in the solid particle to be present in a fixed volume or weight of such composition as compared to previously known compositions. One advantage of the suspension composition provided herein can be for aerial spraying of active ingredient such as herbicides, insecticides, or other growth regulating compounds.
    Type: Grant
    Filed: August 30, 2013
    Date of Patent: April 21, 2015
    Assignee: Rohm and Haas Company
    Inventors: Edward Charles Kostansek, Richard Martin Jacobson
  • Patent number: 9005657
    Abstract: In-situ methods of applying ethylene response manipulation formulations are disclosed. The formulations comprise at least one ethylene response manipulation agent which is at least partially encapsulated, a polyol liquid medium, or a hydrogel medium, or a combination of polyol and hydrogel medium. A preferred ethylene response manipulation agent is 1-methylcyclopropene.
    Type: Grant
    Filed: July 31, 2014
    Date of Patent: April 14, 2015
    Inventor: Nazir Mir
  • Patent number: 8980951
    Abstract: Bicyclic sesquiterpene compounds exhibiting antifungal characteristics are formulated into antifungal compositions for use in the treatment of fungal infections in humans, animals, and plants. Particularly, sesquiterpene alcohols derived from drimane have been discovered to possess broad-spectrum antifungal characteristics. Exemplary antifungal sesquiterpene compounds include albicanol and drimenol, which have been shown effective against a number of pathogenic fungi.
    Type: Grant
    Filed: January 21, 2014
    Date of Patent: March 17, 2015
    Assignee: Kansas State University Research Foundation
    Inventors: Govindsamy Vediyappan, Duy H. Hua
  • Publication number: 20150051298
    Abstract: A method for producing stable nanoemulsions having a desired droplet size and functional properties tailored for use in a specific application (which is referred to as substantially optimizing composition) that includes selecting an aqueous phase; the aqueous phase comprising at least one ingredient from water, surfactant, co-surfactant and co-solvent, the aqueous phase being selected such that a stable nanoemulsions having a desired droplet size and functional properties tailored for use in a specific application is obtained, and selecting an organic phase comprising at least two ingredients from lipophilic component, oil, surfactant, co-surfactant and cosolvent, the organic phase being selected such that a stable nanoemulsions having a desired droplet size and functional properties tailored for use in a specific application is obtained, a nanoemulsion being formed when the organic phase is mixed with the aqueous phase.
    Type: Application
    Filed: August 13, 2014
    Publication date: February 19, 2015
    Inventors: David J. McClements, Amir H. Saberi, Yuhua Chang, Lynne McLandsborough
  • Publication number: 20150037276
    Abstract: The present invention provides a hydrocolloid composition which, based on 100% by weight of the hydrocolloid composition, comprises: 10-90%) by weight of a polyisobutylene tackifier; 5-55% by weight of a hydrophilic absorbing substance; and 0.1-20% by weight of a functional ingredient. The invention further provides an article containing the hydrocolloid composition.
    Type: Application
    Filed: November 8, 2011
    Publication date: February 5, 2015
    Applicant: 3M INNOVATIVE PROPERTIES COMPANY
    Inventors: Ting Fan, Ying Wei Xie, Jing Huang, Kai Qiu, Grace Ho, Dong Wu, Jie Hu
  • Publication number: 20150018430
    Abstract: This invention is related to controlled release formulations of volatile antimicrobial compounds against pathogens affecting meats, plants, or plant parts or dairy products. Provided are delivery systems in the form of coatings or films, where controlled release of their volatile components in vapor form is triggered by high relative humidity. The volatile component may include, for example volatile antimicrobial liquids including low molecular weight alcohols and/or aldehydes, 1-methylcyclopropene, and/or other volatile fungicides.
    Type: Application
    Filed: July 11, 2014
    Publication date: January 15, 2015
    Inventors: Alexander Williamson, Daniel Maclean
  • Publication number: 20150004238
    Abstract: Stable vitamin oil-in-water emulsions and methods of making those emulsions are described herein. The emulsions may be used to make beverage products that include fat-soluble vitamins. The emulsions may also be used in beverage products that are colored and which maintain color stability for an extended period of time.
    Type: Application
    Filed: August 5, 2014
    Publication date: January 1, 2015
    Inventors: Archana N.M.I. Khangaonkar, Jeffrey D. Nutt
  • Patent number: 8912230
    Abstract: The invention relates to the use of a molecule selected from the group which consists of geranyl acetate, geraniol, isomenthone, limonene or a mixture of at least two of the above, for preparing a drug for treating or preventing vascular endothelial cell senescence and subjacent tissue degeneration induced by repeated inflammatory episodes. Specifically, the drug is useful for treating vascular endothelial cell senescence and tissue degeneration induced by repeated inflammatory episodes resulting from the presence of cancer cells.
    Type: Grant
    Filed: October 23, 2006
    Date of Patent: December 16, 2014
    Assignee: Aisa Therapeutics
    Inventor: Patrizia D'Alessio
  • Patent number: 8906967
    Abstract: The present invention relates to the use of sesquiterpenes and derivatives thereof as components of animal feed or feed additives for the improvement of animal performance as well as to the corresponding animal feed or feed additives containing them.
    Type: Grant
    Filed: June 23, 2008
    Date of Patent: December 9, 2014
    Assignee: DSM IP Assets B.V.
    Inventors: Marco Frehner, Riccardo Losa, Patrick Schuepfer
  • Publication number: 20140348764
    Abstract: The present invention provides methods of treating humans and animals with terpenes and terpenoids in order to rejuvenate the skin and increase the protective layer against irradiation by ultraviolet radiation (UVR). More specifically it provides terpenes and terpenoids as ingredients that work as persistent UVR blockers. Terpenes and terpenoid compounds support the growth of skin, skin tissue and keratinocytes and additional UVR-blocking by reason of increased stratum corneum thickness and loricrin content. Both terpenes and terpenoids may be applied topically or orally at oral or topical concentrations from about 6 mg to about 600 mg per kilogram of body weight per day effective to stimulate growth of the skin layer and prevent damage from ultraviolet radiation (UVR).
    Type: Application
    Filed: June 3, 2014
    Publication date: November 27, 2014
    Inventors: Ivica Labuda, Fredric Burns
  • Patent number: 8895629
    Abstract: An improved method for the manufacture of an oil-in-water emulsion involves circulation of emulsion components between a first container and a second container via a homogenizer and/or via a microfluidization device. Usefully, all of the emulsion components from the first container are emptied before being returned.
    Type: Grant
    Filed: December 3, 2010
    Date of Patent: November 25, 2014
    Assignee: Novartis AG
    Inventors: Harald Rueckl, Hanno Scheffczik, Barbara Santry
  • Patent number: 8871816
    Abstract: An improved method for the manufacture of an oil-in-water emulsion involves three procedures: (i) preparation of a preliminary emulsion; (ii) microfluidization of the preliminary emulsion to reduce its droplet size; and (iii) filtration of the microfluidized emulsion through a hydrophilic membrane.
    Type: Grant
    Filed: December 3, 2010
    Date of Patent: October 28, 2014
    Assignee: Novartis AG
    Inventors: Harald Rueckl, Hanno Scheffczik, Barbara Santry
  • Publication number: 20140302169
    Abstract: A method wherein subjects having or at risk for having hyperopia, presbyopia or astigmatism are administered a composition having an effective amount of ocular antioxidants, including specifically macular pigments, to prevent, treat, or delay the onset of age-related macular degeneration (AMD).
    Type: Application
    Filed: June 18, 2014
    Publication date: October 9, 2014
    Inventor: Richard Roberts
  • Publication number: 20140271758
    Abstract: Provided are compositions comprising a collection of overcoated particles wherein each of the overcoated particles comprises a first coating and a second coating. In one embodiment, the first coating comprises water-insoluble material, for example a fatty compound or a waxy material. In another embodiment, the second coating comprises a water-insoluble polymer or water-resistant film, wherein the water-insoluble polymer of the second coating is different than the water-insoluble material of the first coating. Also provided is a slurry comprising water and overcoated powders provided herein. Also provided is a method of contacting plants or plant parts with a composition or slurry provided herein.
    Type: Application
    Filed: March 11, 2014
    Publication date: September 18, 2014
    Applicants: Syngenta Crop Protection LLC, AGROFRESH INC.
    Inventors: Yueqian Zhen, Niall Rae Thomson
  • Publication number: 20140249234
    Abstract: The present invention provides methods of treating humans and animals with terpenes and terpenoids in order to restore the stratum granulosum and stratum corneum and treat a dermatological disease, such as, for instance atopic dermatitis. More specifically it provides terpenes and terpenoids such as monoterpenoids, sesquiterpenes and norisoprenoids as ingredients that work to restore and thicken the stratum granulosum and stratum corneum and treat a dermatological disease. Terpenes and terpenoid compounds support the cell proliferation, cell differentiation, growth of skin, skin tissue and keratinocytes by upregulating genes for loricrin filaggrin, caspase 14, hornerin and other late cornified envelope components and vascular endothelial growth factor (VEGF) and downregulation of matrix metalloproteinases. Both terpenes and terpenoids may be applied topically or orally at oral or topical concentrations from about 0.
    Type: Application
    Filed: June 6, 2012
    Publication date: September 4, 2014
    Inventors: Frederic J. Burns, Ivica Labuda
  • Publication number: 20140242179
    Abstract: The present patent application relates to a novel coating system, coated compositions with such a coating system, as well as to the use of such compositions in the production food, feed, dietary supplements and/or pharmaceutical products, as well as to food, feed, dietary supplements and/or pharmaceutical products comprising such compositions.
    Type: Application
    Filed: October 11, 2012
    Publication date: August 28, 2014
    Applicant: DSM IP ASSETS B.V.
    Inventors: Sylvain Diguet, Bruno H. Leuenberger, Fabien Laboulfie, Mehrdji Hemati
  • Publication number: 20140234398
    Abstract: Some embodiments of the present invention provide pharmaceutical formulations, for treating atherosclerosis in a mammal, including a bile acid and/or a terpene atherosclerotic plaque emulsifier. Some embodiments provide methods for administering such pharmaceutical formulations. In some embodiments, pharmaceutical formulations include a combination of a bile acid and a terpene in amounts effective to result in plaque regression, and the amount of each individual emulsifier in the combination can be lower than an amount that is effective to result in plaque regression when the emulsifier is administered alone. In some embodiments, a statin can be administered simultaneously or sequentially with the pharmaceutical formulation.
    Type: Application
    Filed: April 26, 2013
    Publication date: August 21, 2014
    Applicant: AtheroNova Operations, Inc.
    Inventor: Giorgio Zadini
  • Patent number: 8809398
    Abstract: The present invention relates to a liquid formulation containing at least one carotenoid, at least one hydrophilic protective colloid and at least one water-miscible alcohol. The formulation according to the invention can be added directly to aqueous or non-aqueous preparations. The invention compositions can be used in animal feed, human food or a dietary supplement and in pharmaceutical and cosmetic preparations.
    Type: Grant
    Filed: January 15, 2008
    Date of Patent: August 19, 2014
    Assignee: BASF SE
    Inventors: Christian Köpsel, Jesper Feldthusen Jensen
  • Patent number: 8802140
    Abstract: In-situ methods of applying ethylene response manipulation formulations are disclosed. The formulations comprise at least one ethylene response manipulation agent which is at least partially encapsulated, a polyol liquid medium, or a hydrogel medium, or a combination of polyol and hydrogel medium. A preferred ethylene response manipulation agent is 1-methylcyclopropene.
    Type: Grant
    Filed: January 8, 2014
    Date of Patent: August 12, 2014
    Inventor: Nazir Mir
  • Patent number: 8795699
    Abstract: A method of repelling wasps, which method comprises using a preparation comprising (a) one or more of ethyl 3-(N-n-butyl-N-acetylamino)propionate, dihydronepetalactone, and extract of catmint, and (b) at least one compound selected from certain perfume ingredients. This abstract is neither intended to define the invention disclosed in this specification nor intended to limit the scope of the invention in any way.
    Type: Grant
    Filed: May 14, 2008
    Date of Patent: August 5, 2014
    Assignee: Beiersdorf AG
    Inventors: Rainer Kroepke, Jens Schulz, Jens Nielsen, Stephanie Von Der Fecht
  • Publication number: 20140212507
    Abstract: Disclosed is a method for determining a supplement regime for a subject diagnosed with age-related macular degeneration (AMD). The method involves determining the subject's risk of developing advanced AMD based on their genetic profile for the complement factor H gene and the ARMS2 gene and administering a supplement containing antioxidants and/or zinc based on their risk of developing advanced AMD.
    Type: Application
    Filed: July 31, 2013
    Publication date: July 31, 2014
    Applicant: ArcticDx Inc.
    Inventors: Brent Zanke, Carl Awh
  • Patent number: 8771652
    Abstract: The present invention provides methods of treating humans and animals with terpenes and terpenoids in order to rejuvenate the skin and increase the protective layer against irradiation by ultraviolet radiation (UVR). More specifically it provides terpenes and terpenoids as ingredients that work as persistent UVR blockers. Terpenes and terpenoid compounds support the growth of skin, skin tissue and keratinocytes and additional UVR-blocking by reason of increased stratum corneum thickness and loricrin content. Both terpenes and terpenoids may be applied topically or orally at oral or topical concentrations from about 6 mg to about 600 mg per kilogram of body weight per day effective to stimulate growth of the skin layer and prevent damage from ultraviolet radiation (UVR).
    Type: Grant
    Filed: September 17, 2010
    Date of Patent: July 8, 2014
    Assignees: New York University, Biokeys for Flavors, LLC
    Inventors: Ivica Labuda, Fredric Jay Burns
  • Publication number: 20140187510
    Abstract: The present invention is directed toward a method of treating a subject for a condition mediated by aberrant Wnt/?-catenin signaling by selecting a subject with a condition mediated by aberrant Wnt/?-catenin signaling and administering to the selected subject a compound selected from the group consisting of those set forth in Table 1, Table 2, and a pharmaceutically acceptable salt thereof. A method of similarly modulating the Wnt/?-catenin pathway in a subject is also discussed.
    Type: Application
    Filed: July 11, 2013
    Publication date: July 3, 2014
    Applicants: THE GENERAL HOSPITAL CORPORATION, MASSACHUSETTS INSTITUTE OF TECHNOLOGY, UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR CENTER FOR COMMERCIALIZATION
    Inventors: Randall T. Moon, Travis L. Biechele, Nathan D. Camp, Stephen Haggarty, Daniel Fass
  • Patent number: 8715632
    Abstract: Compositions for treating hair are disclosed. Methods of making and using compositions for treating hair are also disclosed.
    Type: Grant
    Filed: November 26, 2012
    Date of Patent: May 6, 2014
    Inventor: S. Katharine Presty
  • Patent number: 8703195
    Abstract: Disclosed is a method in which poloxamer, a resin, and/or a tocopherol is/are fused, and the material that is to be treated is intimately dispersed with said melt. After being introduced into the melt, the material that is to be treated is coated with water to prevent hardening, and the spontaneously forming gel is homogenized. The obtained product is composed of a transparent gel that is based on at least one poloxamer, a resin or a tocopherol, and an active substance which is solubilized, dispersed, and stabilized therein and whose consistency ranges from solid, semisolid, i.e. aspic-like, to liquid. The micelles of said solubilized matter remain stable even when the same is diluted well below the CMC of poloxamer.
    Type: Grant
    Filed: March 9, 2007
    Date of Patent: April 22, 2014
    Assignee: Biorem AG
    Inventor: Hanspeter Strobel
  • Patent number: 8691253
    Abstract: The invention relates to a method of use, of a mixture of chemical compounds for a shark repellent, as well as methods of protection garments in using such material(s). Generally, there are not many shark repellents. This shark repellent contains a mixture of chemical compounds that are highly toxic and trenchant, which will deter the shark from injured or non-injured humans or animals, once the mixture is immersed in water.
    Type: Grant
    Filed: May 18, 2009
    Date of Patent: April 8, 2014
    Inventor: Rhonda Tracy
  • Publication number: 20140094425
    Abstract: The invention relates to methods for transdifferentiation of body tissues which can be used to generate specific cell types needed for regenerating organs or body parts, following cellular degeneration, injury or amputation. The present invention also describes the use of tissue transdifferentiation for treating cancer and autoimmune diseases.
    Type: Application
    Filed: September 25, 2013
    Publication date: April 3, 2014
    Inventor: Steven BARANOWITZ
  • Publication number: 20140088185
    Abstract: A buccally administered dosage for assisting with the relief of common digestive complaints where the dosage formed into a hard candy dosage drop, where the dosage is a sugar base infused with a botanical derivative that has concentrated active compositions in sufficient concentration to provide a soothing effect of digestive upset, and where the drop has favorable organoleptic properties.
    Type: Application
    Filed: November 27, 2013
    Publication date: March 27, 2014
    Inventors: Dustin Garth James, Helen Kim-James
  • Publication number: 20140086879
    Abstract: Disclosed herein is an isolated Muscodor albus strain producing volatile organic compounds such as aristolene, 3-octanone and/or acetic acid ester, as well as cultures of said strain and compositions, metabolites and volatiles derived from said strain or culture as well as methods of obtaining said compositions, metabolites and volatiles and their methods of use for controlling pests. Also disclosed are artificial compositions having the same components and uses as the volatiles derived from the strain. A method for capturing and sampling the volatiles is also disclosed.
    Type: Application
    Filed: September 23, 2013
    Publication date: March 27, 2014
    Applicant: Marrone Bio Innovations, Inc.
    Inventors: Gary Strobel, Vu Phong Bui, Hai Su, Phyllis Himmel, Pamela Marrone, Lijuan Xing, Sarah Lewis
  • Patent number: 8668921
    Abstract: The present invention provides lipase inhibitors containing dimers of flavan-3-ols derived from teas as well as foods and beverages and medicines containing said inhibitors. More specifically, the present invention provides lipase inhibitors containing at least one of assamicains represented by the formula: wherein G represents a galloyl group; theasinensins represented by the formula: wherein R1 represents G or H, and R2 represents G; and theaflavins represented by the formula: wherein R1 and R2 independently represent G or H; as well as foods and beverages and medicines containing said lipase inhibitors.
    Type: Grant
    Filed: July 5, 2005
    Date of Patent: March 11, 2014
    Assignee: Suntory Holdings Limited
    Inventors: Masaaki Nakai, Yuko Fukui, Sumio Asami, Fumio Hashimoto
  • Patent number: 8663707
    Abstract: A method for treating atherosclerosis in a patient comprising maintaining an elevated level of alcohol in the patient's blood; and administering a calcium chelating agent is provided.
    Type: Grant
    Filed: July 24, 2012
    Date of Patent: March 4, 2014
    Inventor: Ajay J. Panchal
  • Publication number: 20140010859
    Abstract: The invention is directed to microcapsules, pharmaceutical or nutraceutical compositions comprising same, and methods for preparing and using same for delivery of nanoparticle coated emulsions comprising biologically active ingredients. The microcapsule comprises barley protein, oil, and a biologically active ingredient. The microcapsule is degradable to generate a nanoparticle comprising an oil droplet coated with a barley protein.
    Type: Application
    Filed: December 12, 2011
    Publication date: January 9, 2014
    Applicant: THE GOVERNORS OF THE UNIVERSITY OF ALBERTA
    Inventor: Lingyun Chen
  • Patent number: 8609729
    Abstract: Disclosed is a method for treating macular degeneration in a mammalian subject, which comprises administering to the subject in need thereof an effective amount of a 15-keto-prostaglandin compound such as 13,14-dihydro-15-keto-20-ethyl-prostaglandin F2? isopropyl ester.
    Type: Grant
    Filed: April 12, 2010
    Date of Patent: December 17, 2013
    Assignee: Sucampo AG
    Inventors: Ryuji Ueno, John Cuppoletti
  • Patent number: 8604086
    Abstract: The present invention relates to a method of treating and preventing a papillomavirus infection in an individual, comprising administering to the individual a therapeutically effective amount of a condensation polymer of an aromatic sulfonic acid and an aldehyde, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: February 26, 2009
    Date of Patent: December 10, 2013
    Assignee: Endo Pharmaceuticals Solutions Inc.
    Inventor: Albert T. Profy
  • Publication number: 20130280352
    Abstract: The invention relates to pet food compositions designed to induce the animal to cease feeding upon consumption of the appropriate nutritional amount. The invention further provides methods of inducing satiety response in animals and methods of controlling the amount of food intake in animals.
    Type: Application
    Filed: November 23, 2011
    Publication date: October 24, 2013
    Applicant: Hill's Pet Nutrition, Inc.
    Inventor: Samer Al-Murrani
  • Publication number: 20130281533
    Abstract: The present invention provides food compositions and methods for companion animals that are effective in preventing or treating obesity.
    Type: Application
    Filed: November 30, 2011
    Publication date: October 24, 2013
    Applicant: Hill's Pet Nutrition, Inc.
    Inventors: Ryan Michael Yamka, Nolan Zebulon Frantz, Samer Al-Murrani
  • Publication number: 20130274324
    Abstract: The present invention relates to compositions comprising a) 0.1 to 70 weight-% based on the composition of one or more fat-soluble active ingredients; b) one or more plant protein(s) chosen from the group of proteins suitable for food application; and c) one or more soy soluble polysaccharide(s); wherein the sum of the amount of protein(s) and the amount of polysaccharide(s) represents 10 to 85 weight-% based on the composition in dry matter and, wherein the weight ratio of protein(s) to polysaccharide(s) is chosen like 1:b with the proviso that b is comprised between 0.5 and 15.
    Type: Application
    Filed: December 14, 2011
    Publication date: October 17, 2013
    Inventors: Wei Deng, Bruno Leuenberger, Olivia Vidoni, Ping Yao, Baoru Yin
  • Publication number: 20130245053
    Abstract: The present disclosure relates to pesticidal compositions and to methods for controlling pests such as insects and other arthropods. More particularly, the disclosure relates to a pesticidal compositions containing mineral oil and one or more additional components which, when used in combination, act synergistically to control insect and pest populations.
    Type: Application
    Filed: May 8, 2013
    Publication date: September 19, 2013
    Inventor: Steven R. Sims
  • Patent number: 8512723
    Abstract: Antimicrobial compositions, especially those useful when applied topically, particularly to mucosal tissues (i.e., mucous membranes), including, in particular, an antimicrobial lipid component, such as a fatty acid ester, fatty ether, or alkoxide derivative thereof. The compositions can also include an enhancer component, a surfactant, a hydrophobic component, and/or a hydrophilic component. Such compositions provide effective topical antimicrobial activity and are accordingly useful in the treatment and/or prevention of conditions that are caused, or aggravated by, microorganisms (including viruses).
    Type: Grant
    Filed: September 8, 2004
    Date of Patent: August 20, 2013
    Assignee: 3M Innovative Properties Company
    Inventors: Matthew T. Scholz, Dianne L. Gibbs, John T. Capecchi, Jeffrey F. Andrews
  • Patent number: 8507562
    Abstract: The present invention provides convergent processes for preparing (?)-beta-elemene, (?)-beta-elemenal, (?)-beta-elemenol, and (?)-beta-elemene fluoride and analogues thereof. Also provided are intermediates useful for preparing (?)-beta-elemene. The present invention further provides novel compositions based on analogues of (?)-beta-elemene, (?)-beta-elemenal, (?)-beta-elemenol, (?)-beta-elemene fluoride and methods for the treatment of cancer, such as brain tumor, lung cancer, breast cancer, prostate cancer, ovarian cancer, colorectal cancer, gastric intestional cancer, and stomach cancer.
    Type: Grant
    Filed: January 4, 2007
    Date of Patent: August 13, 2013
    Assignee: HYWE Pharmaceuticals, Inc.
    Inventor: Lan Huang
  • Patent number: 8501163
    Abstract: A carotenoid substance called zeaxanthin, when ingested orally at suitable dosages, can provide effective protection against sunburns and darken the skin to emulate a healthy suntan. Zeaxanthin may induce: (i) a mild but noticeable tinting, shading, or darkening of skin color, comparable to a mild suntan; (ii) a substantial increase in the person's ability to withstand elevated levels of sun or UV exposure; and, (iii) an increased ability of reddened and sunburned skin to convert into intact skin that looks browned and healthily tanned. Topical formulations containing zeaxanthin can be administered to the skin during the time period of ingesting the oral formulation to further protect the skin and provide an additional darkening of the skin.
    Type: Grant
    Filed: July 18, 2012
    Date of Patent: August 6, 2013
    Assignee: ZeaVision LLC
    Inventors: Dennis L. Gierhart, Joseph A. Fox
  • Patent number: 8492443
    Abstract: Topical formulations and methods use are described herein for relieving symptoms created by herpes simplex, mouth ulcers, and yeast infections. The formulations comprise effective amounts of d-limonene.
    Type: Grant
    Filed: May 31, 2006
    Date of Patent: July 23, 2013
    Inventor: Joe S. Wilkins, Jr.
  • Publication number: 20130183281
    Abstract: Methods of treating and evaluating subjects having neoactive mutants of IDH (e.g., IDH1 or IDH2).
    Type: Application
    Filed: April 20, 2012
    Publication date: July 18, 2013
    Inventors: Shin-San Michael Su, Lenny Dang, Stefan Gross, Shengfang Jin, Valeria Fantin
  • Patent number: RE46906
    Abstract: An improved method for the manufacture of an oil-in-water emulsion involves three procedures: (i) preparation of a preliminary emulsion; (ii) microfluidization of the preliminary emulsion to reduce its droplet size; and (iii) filtration of the microfluidized emulsion through a hydrophilic membrane.
    Type: Grant
    Filed: October 13, 2015
    Date of Patent: June 26, 2018
    Assignee: NOVARTIS AG
    Inventors: Harald Rueckl, Hanno Scheffczik, Barbara Santry